News

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Frontier Capital Management, an investment management company, released its “Frontier Small Cap Growth Fund” first quarter ...
Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 healthcare AI stocks to buy according to hedge funds. On June 30, 2025, ...
Tempus AI's innovation in genomics, data, and applications makes the company well positioned to become a contender in the AI ...
In a statement, Tempus AI, Inc. (NASDAQ:TEM) said that it plans to raise the funds through a convertible senior notes ...
The latest update is out from Tempus AI, Inc. Class A ( (TEM) ).
Tempus AI Inc. (NASDAQ:TEM) is one of the best AI stocks to buy according to hedge funds. On June 25, Ambry Genetics, which ...
Analysts have recently evaluated Tempus AI and provided 12-month price targets. The average target is $67.88, accompanied by a high estimate of $70.00 and a low estimate of $60.00. Observing a 7.75% ...
Tempus AI (TEM) on Monday announced the pricing of $650 million aggregate principal amount of 0.75% Convertible Senior Notes due 2030.
Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining ...